JNCE - Jounce Therapeu Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (1.05%) AAPL (2.83%) PTON (0.42%) GPRO (3.01%) AGRX (14.96%) NVAX (-15.65%) AAOI (-2.42%) LEDS (0.5%) LAKE (-13.05%) JPM (1.82%) JNJ (0.51%) JEF (1.17%) INTC (2.47%) HOME (2.25%) HEXO (-0.76%) HAL (1.99%) FDX (-0.07%) FB (1.36%) ENDP (-2.93%) ELOX (-1.73%) CVX (0.67%) CVM (6.94%) CMCSA (0.1%) BTCUSD (%) BABA (2.32%)

Is Jounce Therapeutics (JNCE) Stock Outp...	12/20/19
Is (JNCE) Outperforming Other Medical Stocks This Year?

Is the Options Market Predicting a Spike...	12/05/19
Investors need to pay close attention to Jounce Therapeutics (JNCE) stock based on the movements in the options market lately.

The Daily Biotech Pulse: Aurinia Rips Hi...	12/05/19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Dec. 4) A...

Jounce Therapeutics, Inc. (JNCE) Reports...	08/07/19
Jounce Therapeutics, Inc. (JNCE) delivered earnings and revenue surprises of 19.23% and 2.08%, respectively, for the quarter ended June 2019. Do the n...

2 Promising $5 Biotech Stocks to Conside...	07/29/19
Jounce Therapeutics (JNCE) and Ocular Therapeutix (OCUL) are two promising biotech stocks selling for less than $5 that each provided investors with p...

What To Know About Jounce's Amended Lice...	07/24/19
Jounce Therapeutics Inc (NASDAQ: JNCE ) shares are trading higher after the company announced an amended licensing agreement with Celgene Corporation ...

Jounce Therapeutics, Inc. (JNCE) CEO Dr....	05/09/19
No summary available.

Peloton IPO: Expects To Start Phase 3 Tr...	05/09/19
No summary available.

Jounce Therapeutics, Inc. (JNCE) Reports...	05/08/19
Jounce Therapeutics, Inc. (JNCE) delivered earnings and revenue surprises of -22.58% and -25.55%, respectively, for the quarter ended March 2019. Do t...

Jounce Therapeutics Q1 top line off 2%	05/08/19
No summary available.

HOLDERS

% Insider	12.52%	% Institutional	76.43%

Top 10 Institutional Owners

Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%

Previous Close	$6.46	Open	$6.49
Volume	357.3K	Market Cap	151.67M
Yield		Last Dividend

Date	2019-11-07 (BMO)	Est. (EPS/Rev.)	$2.24/ 102.34M
Actual (EPS/Rev.)	$2.90/ $119.45 M	EPS (TTM)	0

Total Revenue	$1.3B	Total Liabilities	$2.1B
Cost of Revenue	$2.5B	Total cash flow	$3.2
Total Assets	$29.98B

Service Name	Trader	% Success
Tech Trades	Ravi	91.00 %	Follow
Big Data Kornacki & Zhou	Zhou Academy	86.00 %	Subscribe
Arbitrage Trade Analytics	Royce Wells	72.00 %	Subscribe
Tech and Biotech Catalysts	Michael	43.00 %	Subscribe

JNCE - Jounce Therapeutics

$6.76 0.3[4.65%]

Add to New List:

Day

52 Week

ANALYST RATINGS

0.00 %

Price Target (PT)

EARNINGS

FINANCE

HOLDERS

Top 10 Institutional Owners

TRADERS TRACKING $JNCE

About Us

Product Types

Strategies

Follow Us

Secure Payments